References
1.
Beauparlant P,
Papp K,
Haraoui B. The incidence of cancer associated
with the treatment of rheumatoid arthritis.
Seminars in Arthritis & Rheumatism. 29(3):148-58, 1999.
Silman AJ,
Petrie J,
Hazleman B,
Evans SJ.
Lymphoproliferative cancer and other malignancy in patients with
rheumatoid arthritis treated with azathioprine: a 20-year follow up study.
Annals of the Rheumatic Diseases. 47(12):988-92, 1988.
Kauppi M,
Pukkala
E,
Isomaki
H. Excess risk of lung cancer in patients with rheumatoid arthritis
Journal of Rheumatology. 23(8):1484-5, 1996.
2. Zlowodzki M, Allen B, Schreibman KL, Vance RB, Kregor PJ. CASE REPORTS: malignant fibrous histiocytoma of bone arising in chronic osteomyelitis. Clin Orthop Relat Res. 2005 Oct;439:269-73.
3.
Lewis JG,
Pohl C, Hombach A,
Kruis W.
Chronic inflammatory bowel disease and cancer. Hepato-Gastroenterology.
47(31):57-70, 2000.
Dennis
LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and
prostate cancer. Urology 2002 Jul;60(1):78-83.
Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5258-65.
4. O'Hanlon DM, Lynch J, Cormican M, Given HF. The acute phase response in breast carcinoma. Anticancer Res. 2002 Mar-Apr;22(2B):1289-93.
Nakashima J, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Ohigashi T, Murai M. Simple stratification of survival using bone scan and serum C-reactive protein in prostate cancer patients with metastases. Urol Int. 2008;80(2):129-33.
Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW.
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer. 2005 Jan 17;92(1):21-3.
Hara M, Matsuzaki Y, Shimuzu T, Tomita M, Ayabe T, Enomoto Y, Onitsuka T.
Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res. 2007 Jul-Aug;27(4C):3001-4.
Lee YT, Haymond HR, Feder B. Biochemical evaluation of patients with breast cancer.
J Surg Oncol. 1982 Apr;19(4):197-200.
5.
Harris RE, Chlebowski RT,
Fischer
SM, Lo HH et al. The effects of
NSAIDs on breast cancer prognostic factors.
Oncol Rep. 1999; 25:433-5.
Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol. 2007 Sep 15;166(6):709-16.
6. Blair CK, Sweeney C, Anderson KE, Folsom AR. NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat. 2007 Jan;101(2):191-7.
7.
Geissbuhler P,
Mermillod B,
Rapin CH.
Elevated serum vitamin B12 levels associated with CRP as a predictive
factor of mortality in palliative care cancer patients: a prospective study over
five years. Journal of Pain & Symptom Management. 20(2):93-103, 2000
Toniatti C,
Arcone R,
Majello
B,
Ganter U,
Arpaia G,
Ciliberto G. Regulation
of the human C-reactive protein gene, a major marker of inflammation and cancer.
Molecular Biology & Medicine. 7(3):199-212, 1990
Cooper
EH. Acute phase reactant proteins as
prognostic indicators in cancer. Tokai Journal of Experimental & Clinical
Medicine. 13(6):361-4, 1988
8.
Arlt A, Schafer H.
NFkappaB-dependent chemoresistance in solid tumors.
Int J Clin Pharmacol Ther. 2002 Aug;40(8):336-47.
Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms.
Curr Opin Genet Dev. 2008 Feb;18(1):19-26.
9. Mitry E, Taleb-Fayad R, Deschamps A, Mansencal N, Lepère C, Declety G, Lièvre A, Vaillant JN, Lesur G, Cramer E, Dubourg O, Rougier P. Risk of venous thrombosis in patients with pancreatic adenocarcinoma. Gastroenterol Clin Biol. 2007 Dec;31(12):1139-42.
Baker EA, El-Gaddal S, Williams L, Leaper DJ. Profiles of inflammatory cytokines following colorectal surgery: relationship with wound healing and outcome. Wound Repair Regen. 2006 Sep-Oct;14(5):566-72.
Williams J, Chen Y, Rubin P, Finkelstein J, Okunieff P. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003 Jul;13(3):182-8.
10. Colvin L, Fallon M. Challenges in cancer pain management-bone pain. Eur J Cancer. 2008 May;44(8):1083-1090.
Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun. 2007 Oct;21(7):863-71.
Jacober ML, Mamoni RL, Lima CS, Dos Anjos BL, Grotto HZ. Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia.
Med Oncol. 2007;24(3):323-9.
11. MacDonald N. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. J Support Oncol. 2007 Apr;5(4):157-62;
12.
Fauve RM.
Some aspects of the macrophage-cancer relationship. Research in
Immunology. 1993;144(4):265-8
Kopper L,
Lapis K.
What's new in macrophage-tumor cell interaction?. Pathology, Research &
Practice. 179(6):652-5, 1985
Van Netten JP,
Ashmead
BJ,
Parker
RL,
Thornton
IG,
Fletcher
C,
Cavers D,
Coy P,
Brigden
ML. Macrophage-tumor cell associations: a factor in metastasis of
breast cancer? Journal of Leukocyte Biology. 1993;54(4):360-2
Pass HI,
Mew D,
Pass HA,
Temeck
BK. The macrophage, TNF,
and other cytokines. Chest Surgery Clinics of
Heilbronn LK, Campbell LV.
Adipose tissue macrophages, low grade inflammation and insulin resistance in
human obesity. Curr Pharm Des. 2008;14(12):1225-30.
13.
Bours V, Dejardin E,
Goujon-Letawe F, Merville MP,
Castronovo V The NF-kappa B transcription factor and cancer: high expression of
NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochemical
Pharmacology. 47(1):145-9, 1994
Bhat-Nakshatri P, Newton TR, Goulet
R Jr, Nakshatri H. NF-kappaB activation and interleukin 6 production in
fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin
1alpha. Proceedings of the
14. Baniyash M, Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol. 2006 Feb;16(1):80-8.
15.
Rose DP,
Connolly
JM. Regulation of tumor angiogenesis by dietary fatty acids and
eicosanoids. Nutrition & Cancer. 37(2):119-27, 2000
Kimura YN, Watari K, Fotovati A, Hosoi F, Yasumoto K, Izumi H, Kohno K, Umezawa K, Iguchi H, Shirouzu K, Takamori S, Kuwano M, Ono M. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis.
Cancer Sci. 2007 Dec;98(12):2009-18.
16.
Gasic GJ. Role of plasma, platelets,
and endothelial cells in tumor metastasis.
Cancer Metastasis Rev 1984; 3(2):99-114
Liu HM,
Wang DL, Liu CY: Interactions
between fibrin, collagen and endothelial cells in angiogenesis.
Adv Exp Med Biol 1990; 281:3 19-31
Thompson
WD, Harvey JA, Kazmi MA, et al:
Fibrinolysis and angiogensis in wound healing.
17.
Tran-Thang C,
Kruithof E, Lahm H, Schuster
WA, Tada M, Sordat B. Modulation of the plasminogen activation system by
inflammatory cytokines in human colon carcinoma cells. British Journal of
Cancer. 1996;74(6):846-52
Skrzydlewska E, Sulkowska M, Koda M, Sulkowski S. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol. 2005 Mar 7;11(9):1251-66.
18. Lantz RC, Chen GJ, Sarihan M, Sólyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 2007 Feb;14(2-3):123-8.
Rao CV. Regulation of COX and LOX by curcumin.
Adv Exp Med Biol. 2007;595:213-26.
19.
Kodama J,
Miyagi Y,
Seki N,
Tokumo K,
Yoshinouchi M,
Kobashi
Y,
Okuda H,
Kudo T.
Serum C-reactive protein as a prognostic factor in patients with epithelial
ovarian cancer. European Journal of
Obstetrics, Gynecology, & Reproductive Biology. 82(1):107-10, 1999
Karamouzis MV, Papavassiliou AG. COX-2 inhibition in cancer therapeutics: a
field of controversy or a magic bullet? Expert Opin Investig Drugs. 2004
Apr;13(4):359-72.
Milas L,
Mason KA, Crane CH, Liao Z, Masferrer J. Improvement of radiotherapy or
chemoradiotherapy by targeting COX-2 enzyme. Oncology (Huntingt). 2003 May;17(5
Suppl 5):15-24.
Blanke
CD. Celecoxib with chemotherapy in
colorectal cancer. Oncology
(Huntingt). 2002 Apr;16(4 Suppl 3):17-21.
Arlt A,
Schafer H. NFkappaB-dependent
chemoresistance in solid tumors. Int
J Clin Pharmacol Ther. 2002 Aug;40(8):336-47.
20.
Toniatti
C,
Arcone R,
Majello
B,
Ganter U,
Arpaia G,
Ciliberto G. Regulation
of the human C-reactive protein gene, a major marker of inflammation and cancer.
Molecular Biology & Medicine. 7(3):199-212, 1990
Cooper
EH. Acute phase reactant proteins as
prognostic indicators in cancer. Tokai Journal of Experimental & Clinical
Medicine. 13(6):361-4, 1988
Geissbuhler P.
Mermillod B.
Rapin CH.
Elevated serum vitamin B12 levels associated with CRP as a predictive
factor of mortality in palliative care cancer patients: a prospective study over
five years. Journal of Pain & Symptom Management. 20(2):93-103, 2000
Gridelli
C, Gallo C, Ceribelli A, Gebbia V, Gamucci T, Ciardiello F, Carozza F, Favaretto
A, Daniele B, Galetta D, Barbera S, Rosetti F, Rossi A, Maione P, Cognetti F,
Testa A, Di Maio M, Morabito A, Perrone F; GECO investigators.
Factorial phase III randomised trial of rofecoxib and prolonged constant
infusion of gemcitabine in advanced non-small-cell lung cancer: the
GEmcitabine-COxib in NSCLC (GECO) study.Lancet
Oncol. 2007 Jun;8(6):500-12.
21.
Curran WJ. Radiation-induced toxicities; the role of radioprotectants. Sem Rad
Oncol 1998;8(4, Supp1): 2-4
Chen Y,
Rubin P, Williams J, Hernady E, Smudzin T, Okunieff P.
Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat
Oncol Biol Phys. 2001 Mar 1;49(3):641-8.
Inoue A,
Kunitoh H, Sekine I, Sumi M, Tokuuye K, Saijo N.
Radiation pneumonitis in lung cancer patients: a retrospective study of risk
factors and the long-term prognosis. Int J
Radiat Oncol Biol Phys. 2001 Mar 1;49(3):649-55.
22.
Lin E, Morris JS, Ayers GD. Effect of celecoxib on capecitabine-induced
hand-foot syndrome and antitumor activity. Oncology (Huntingt). 2002 Dec;16(12
Suppl No 14):31-7.
Bower
JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in
breast cancer survivors.
Psychosom Med. 2002
Jul-Aug;64(4):604-11.
Takahide N, Naonori
U, et al. A pivotal role of cytosolic phospholipase
A2 in bleomycin-induced pulmonary fibrosis. May 2002 Volume 8 Number 5 pp 480 -
484
Burns
CP, Halabi S, Clamon G, Kaplan E, Hohl RJ, Atkins JN, Schwartz MA, Wagner BA,
Paskett E.
Phase II
study of high-dose fish oil capsules for patients with cancer-related cachexia.
Cancer 2004;101:370-378.
Fearon
KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van
Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ.
Effect of a protein and energy dense N-3 fatty acid enriched oral
supplement on loss of weight and lean tissue in cancer cachexia: a randomised
double blind trial. Gut. 2003; 52(10):1479-86
23. Mills PJ, Ancoli-Israel S, Parker B, Natarajan L, Hong S, Jain S, Sadler GR, von Känel R. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav Immun. 2008 Jan;22(1):98-104.
24. Fearon KC, Voss AC, Hustead DS; Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006 Jun;83(6):1345-50.
MacDonald N. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. J Support Oncol. 2007 Apr;5(4):157-62.
25.
Saetta M.
Airway inflammation in chronic obstructive pulmonary disease.
American Journal of Respiratory & Critical Care Medicine. 160(5 Pt
2):S17-20, 1999
Roth MD,
Arora A,
Barsky
SH,
Kleerup
EC,
Simmons
M,
Tashkin
DP. Airway inflammation
in young marijuana and tobacco smokers.
American Journal of Respiratory & Critical Care Medicine.
157(3 Pt 1):928-37, 1998
Rutgers SR,
Postma DS,
ten Hacken NH,
Kauffman HF,
van Der Mark TW,
Koeter GH,
Timens W.
Ongoing airway inflammation in patients with
COPD who do not currently smoke.
Thorax. 55(1):12-8, 2000
26.
Cerami C.
Founds H.
Nicholl
I.
Mitsuhashi T.
Giordano
D.
Vanpatten S.
Lee A.
Al-Abed
Y.
Vlassara
H.
Bucala R.
Cerami A.
Tobacco smoke is a source of toxic reactive glycation products.
Proceedings of the
27. Nakamura H, Haruki T, Adachi Y, Fujioka S, Miwa K, Taniguchi Y. Smoking affects prognosis after lung cancer surgery. Surg Today. 2008;38(3):227-31.
28. Green JP, Lynn SJ, Montgomery GH. Gender-related differences in hypnosis-based treatments for smoking: a follow-up meta-analysis. Am J Clin Hypn. 2008 Jan;50(3):259-71.
White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD000009.
29. Yuan H, Wong LS, Bhattacharya M, Ma C, Zafarani M, Yao M, Schneider M, Pitas RE, Martins-Green M. The effects of second-hand smoke on biological processes important in atherogenesis. BMC Cardiovasc Disord. 2007 Jan 8;7:1.
30.
Horrobin
DF. A biochemical basis
for alcoholism and alcohol-induced damage including the fetal alcohol syndrome
and cirrhosis: interference with essential fatty acid and prostaglandin
metabolism. Medical Hypotheses.
6(9):929-42, 1980
31.
Arai M,
Okuno F,
Nagata S,
Shigeta
Y,
Takagi S,
Ebihara
Y,
Kobayashi T,
Ishii H,
Tsuchiya
M. Platelet dysfunction
and alteration of prostaglandin metabolism after chronic alcohol consumption.
Scandinavian Journal of Gastroenterology. 21(9):1091-7, 1986
32.
Horrobin
DF. A biochemical basis
for alcoholism and alcohol-induced damage including the fetal alcohol syndrome
and cirrhosis: interference with essential fatty acid and prostaglandin
metabolism. Medical Hypotheses.
6(9):929-42, 1980.
33.
Vgontzas AN, Bixler EO, Lin HM et al. Chronic insomnia is associated with
nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical
implications. J. Clin. Endocrinol. Metab. 2001; 86: 3787-94.
Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP.
Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004 May;89(5):2119-26.
Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am. 2002 Mar;31(1):15-36.
34.
Rudell B,
Blomberg A,
Helleday R,
Ledin MC,
Lundback B,
Stjernberg N,
Horstedt P,
Sandstrom T.
Bronchoalveolar inflammation after exposure
to diesel exhaust: comparison between unfiltered and particle trap filtered
exhaust. Occupational &
Environmental Medicine. 56(8):527-34, 1999
Torres A,
Utell MJ,
Morow PE,
Voter KZ,
Whitin
JC,
Cox C,
Looney
RJ,
Speers
DM,
Tsai Y,
Frampton
MW. Airway inflammation
in smokers and nonsmokers with varying responsiveness to ozone.
American Journal of Respiratory & Critical Care Medicine. 156(3 Pt
1):728-36, 1997
Sjogren
B. Occupational exposure
to dust: inflammation and ischaemic heart disease. Occupational & Environmental
Medicine. 54(7):466-9, 1997
Kim SH, Johnson VJ, Sharma RP. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide. 2002 Aug;7(1):67-74.
Ilback NG, Wesslen L, Fohlman J, Friman G. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis). Toxicol Lett. 1996 Dec;89(1):19-28.
Rylander R,
Thorn J,
Attefors R.
Airways inflammation among workers in a paper
industry. European Respiratory
Journal. 13(5):1151-7, 1999
35.
Hellsten Y,
Frandsen U,
Orthenblad N,
Sjodin B,
Richter
EA. Xanthine oxidase in
human skeletal muscle following eccentric exercise: a role in inflammation.
Journal of Physiology. 498 ( Pt 1):239-48, 1997
Pyne DB. Exercise-induced muscle damage and
inflammation: a review. Australian Journal of Science & Medicine in Sport.
26(3-4):49-58, 1994.
36. Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, Dandona P.
Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr. 2004 Apr;79(4):682-90.
37.
Hwang DH, Kinsella JE. The effects
of trans trans methyl linoleate on the concentration of prostaglandins and their
precursors in rat.
Prostaglandins.
17(4):543-59, 1979.
Chrysohoou C,
Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C.
Adherence to
the Mediterranean diet attenuates inflammation and coagulation process in
healthy adults: The ATTICA Study. J
Am Coll Cardiol. 2004 Jul 7;44(1):152-8.
Simopoulos AP, Robinson J. The Omega
Plan. HarperCollins, 1998.
p. 29
Simopoulos AP. Evolutionary aspects of omega-3 fatty acids in the food supply.
Prostaglandins Leukotrienes & Essential Fatty Acids. 60(5-6):421-9, 1999.
Blok WL,
Cathcart ES,
Gonnerman WA, Leslie CA,
Hayes KC.
Dietary n-3 fatty acids and arthritis. Journal of Internal
Medicine. Supplement. 1989;
225(731):217-23
Leslie CA, Conte
JM, Hayes KC, Cathcart ES. A fish oil diet reduces
the severity of collagen induced arthritis after onset of the disease.
Clinical & Experimental Immunology.
1988; 73(2):328-32
38. Nanri A, Yoshida D, Yamaji T, Mizoue T, Takayanagi R, Kono S. Dietary patterns and C-reactive protein in Japanese men and women. Am J Clin Nutr. 2008 May;87(5):1488-96.
39.
Sugano M, Ikeda I. Metabolic
interactions between essential and trans-fatty acids. Current Opinion in
Lipidology. 7(1):38-42, 1996
Kinsella JE,
Bruckner G, Mai J, Shimp J.
Metabolism of trans fatty acids with emphasis on the
effects of trans, trans-octadecadienoate on lipid composition, essential fatty
acid, and prostaglandins: an overview.
American Journal of Clinical Nutrition. 34(10):2307-18, 1981
40.
Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM.
Relation between a diet with a high glycemic load and plasma
concentrations of high-sensitivity C-reactive protein in middle-aged women.
Am J Clin Nutr. 2002 Mar;75(3):492-8.
41.
Baxter GJ, Graham AB,
42.
Winyard PG, Blake DR. Antioxidants,
redox-regulated transcription factors, and inflammation.
Advances in Pharmacology. 1997; 38:403-21
Conner
EM,
Grimble
RF. Nutritional antioxidants and the
modulation of inflammation: theory and practice.
New Horizons. 1994;
2(2):175-85
43.
Manthey JA. Biological properties of flavonoids pertaining to inflammation.
Microcirculation. 2000;7(6 Pt 2):S29-34.
Murch
SJ, Simmons CB, Saxena PK. Melatonin in feverfew and other medicinal plants.
Lancet. 1997 Nov 29;350(9091):1598-9.
Liang
YC,
Lupulescu A. Prostaglandins, their
inhibitors and cancer.
Prostaglandins Leukotrienes & Essential Fatty Acids. 1996; 54(2):83-94
Seeram
NP, Momin RA, Nair MG, Bourquin LD. 2001. Cyclooxygenase inhibitory and
antioxidant cyanidin glycosides in cherries and berries. Phytomedicine.
Sep;8(5):362–9.
44. Silva Bezerra F, Valença SS, Lanzetti M, Pimenta WA, Castro P, Gonçalves Koatz VL, Porto LC. Alpha-tocopherol and ascorbic acid supplementation reduced acute lung inflammatory response by cigarette smoke in mouse. Nutrition. 2006 Nov-Dec;22(11-12):1192-201.
Krakauer T, Buckley M. The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappaB.
Immunopharmacol Immunotoxicol. 2008;30(1):163-79.
Filomeni G, Aquilano K, Rotilio G, Ciriolo MR. Antiapoptotic response to induced GSH depletion: involvement of heat shock proteins and NF-kappaB activation. Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):446-55.
Accinni R, Rosina M, Bamonti F, Della Noce C, Tonini A, Bernacchi F, Campolo J, Caruso R, Novembrino C, Ghersi L, Lonati S, Grossi S, Ippolito S, Lorenzano E, Ciani A, Gorini M. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):121-7.
46. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007 Sep;86(3):s843-57.
47.
Geissbuhler P.
Mermillod B.
Rapin CH.
Elevated serum vitamin B12 levels associated with CRP as a predictive
factor of mortality in palliative care cancer patients: a prospective study over
five years. Journal of Pain & Symptom Management. 20(2):93-103, 2000
Toniatti C,
Arcone R,
Majello
B,
Ganter U,
Arpaia G,
Ciliberto G. Regulation
of the human C-reactive protein gene, a major marker of inflammation and cancer.
Molecular Biology & Medicine. 7(3):199-212, 1990
Cooper
EH. Acute phase reactant proteins as
prognostic indicators in cancer. Tokai Journal of Experimental & Clinical
Medicine. 13(6):361-4, 1988
48.
Peairs
AT, Rankin JW. Inflammatory Response to a High-fat, Low-carbohydrate
Weight Loss Diet: Effect of Antioxidants. Obesity (
Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008 Mar 15;44(6):1203-8.
49. Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE. Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr. 2006 Apr;136(4):981-6.
He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, Chan AS, Lu AP. Anti-inflammatory and anti-oxidative effects of cherries on Freund's adjuvant-induced arthritis in rats. Scand J Rheumatol. 2006 Sep-Oct;35(5):356-8.
50. Jolad SD, Lantz RC, Solyom AM, Chen GJ, Bates RB, Timmermann BN. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry. 2004 Jul;65(13):1937-54.
Grzanna R, Lindmark L, Frondoza CG. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005 Summer;8(2):125-32.
51. Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit Nuclear Factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond). 2008 Jun 12;5(1):17.
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.
Clin Cancer Res. 2004 Oct 15;10(20):6847-54.
Sun J, Guo W, Ben Y, Jiang J, Tan C, Xu Z, Wang X, Bai C. Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats.
Crit Care Med. 2008 Apr;36(4):1205-13.
Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity.
J Agric Food Chem. 2007 Dec 12;55(25):10150-5.
Yang P, Cartwright C, Chan D, Vijjeswarapu M, Ding J, Newman RA. Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation. Cancer Biol Ther. 2007 Feb;6(2):228-36.
Sandur SK, Ahn KS, Ichikawa H, Sethi G, Shishodia S, Newman RA, Aggarwal BB.
Zyflamend, a polyherbal preparation, inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of NF-kappa B activation and NF-kappa B-regulated gene products. Nutr Cancer. 2007;57(1):78-87.
Yang P, Chan
D, Felix E, Madden T,
Rafailov S, Cammack S, Stone BA, Katz AE. The role of Zyflamend, an herbal anti-inflammatory, as a potential chemopreventive agent against prostate cancer: a case report.
Integr Cancer Ther. 2007 Mar;6(1):74-6.
52. Gupta I, Gupta V, Parihar A, Gupta S, Lüdtke R, Safayhi H, Ammon HP. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3(11):511-4.
Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. 1992 Jun;261(3):1143-6.
53. Teucher T, Obertreis B, Ruttkowski T, Schmitz H. [Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract].
Arzneimittelforschung. 1996 Sep;46(9):906-10.
54. Lee EY, Lee CK, Lee KU, Park JY, Cho KJ, Cho YS, Lee HR, Moon SH, Moon HB, Yoo B. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int. 2007 Jan;27(3):225-33.
Lee CK, Lee EY, Kim YG, Mun SH, Moon HB, Yoo B. Alpha-lipoic acid inhibits TNF-alpha induced NF-kappa B activation through blocking of MEKK1-MKK4-IKK signaling cascades. Int Immunopharmacol. 2008 Feb;8(2):362-70.
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.
Clin Cancer Res. 2004 Oct 15;10(20):6847-54.
Hidalgo GE, Zhong L, Doherty DE, Hirschowitz EA. Plasma PGE-2 levels and altered cytokine profiles in adherent peripheral blood mononuclear cells in non-small cell lung cancer (NSCLC). Mol Cancer. 2002 Nov 12;1:5.
56.
Eustachio B. Opuscula anatomica.
Singh U, Jialal I. Anti-inflammatory effects of alpha-tocopherol. Ann N Y Acad Sci. 2004 Dec;1031:195-203.
Godbout JP, Berg BM, Krzyszton C, Johnson RW. Alpha-tocopherol attenuates NFkappaB activation and pro-inflammatory cytokine production in brain and improves recovery from lipopolysaccharide-induced sickness behavior. J Neuroimmunol. 2005 Dec;169(1-2):97-105.
57. Devaraj S, Chan E, Jialal I. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab. 2006 Nov;91(11):4489-96
58.
Yang P, Chan D, Cartwright C, Felix E, Madden T, Block KI, Newman RA.
Antitumor activity of
fish oils against human lung cancer is associated with altered formation of PGE2
and PGE3 and regulation of Akt phosphorylation. Fifth AACR
International Conference on Frontiers in Cancer Prevention Research, Nov 12-15,
2006.